Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
BKYI

BKYI - Bio-key International Inc Stock Price, Fair Value and News

$0.76+0.21 (+38.18%)
Market Closed

49/100

BKYI

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

49/100

BKYI

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$0.59

Target 3M

$0.58

Target 6M

$0.58

BKYI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BKYI Price Action

Last 7 days

31.0%

Last 30 days

35.7%

Last 90 days

-1.3%

Trailing 12 Months

-49.7%

BKYI RSI Chart

BKYI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BKYI Valuation

Market Cap

8.2M

Price/Earnings (Trailing)

-1.94

Price/Sales (Trailing)

1.18

EV/EBITDA

-1.54

Price/Free Cashflow

-2.46

BKYI Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$0.59

Target 3M

$0.58

Target 6M

$0.58

BKYI Fundamentals

BKYI Revenue

Revenue (TTM)

7.0M

Rev. Growth (Yr)

-27.75%

Rev. Growth (Qtr)

-8.67%

BKYI Earnings

Earnings (TTM)

-4.3M

Earnings Growth (Yr)

-30.57%

Earnings Growth (Qtr)

17.35%

BKYI Profitability

Operating Margin

53.67%

EBT Margin

-61.10%

Return on Equity

-70.36%

Return on Assets

-42.06%

Free Cashflow Yield

-40.68%

BKYI Investor Care

Shares Dilution (1Y)

246.54%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20257.1M6.6M7.0M0
20247.8M7.0M7.3M0
20237.3M7.2M7.7M7.8M
20225.2M6.1M6.2M7.0M
20214.2M4.9M5.2M5.1M
20202.2M1.8M2.3M2.8M
20193.8M3.7M3.4M2.3M
20185.7M5.6M5.4M4.0M
20174.0M4.4M4.9M6.3M
20165.0M3.2M2.9M3.0M
20153.3M5.2M4.5M5.3M
20142.5M2.5M3.4M4.0M
20133.7M3.6M3.6M2.0M
20123.5M3.1M2.9M4.3M
20113.5M3.5M3.5M3.5M
20100003.5M
Get all data in R, Python etc through our Historical Stock Data APIs

About Bio-key International Inc

BKYI
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.
 CEO
 WEBSITEbio-key.com
 SECTORIndustrials
 INDUSTRYSecurity & Protection Services
 EMPLOYEES51

Bio-key International Inc Frequently Asked Questions

BKYI is the stock ticker symbol of Bio-key International Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Bio-key International Inc is 8.24 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check BKYI's fair value in chart for subscribers.

The fair value guage provides a quick view whether BKYI is over valued or under valued. Whether Bio-key International Inc is cheap or expensive depends on the assumptions which impact Bio-key International Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BKYI.

As of Wed Jan 28 2026, BKYI's PE ratio (Price to Earnings) is -1.94 and Price to Sales (PS) ratio is 1.18. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BKYI PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Bio-key International Inc has provided -0.449 (multiply by 100 for percentage) rate of return.